Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: A Randomized, Double-Blind, Controlled Trial (RCT)

NCT01584726 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT01584726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01584726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: A Randomized, Double-Blind, Controlled Trial (RCT)
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2012
Completion date
December 31, 2015
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma